Roy N S, Wang S, Harrison-Restelli C, Benraiss A, Fraser R A, Gravel M, Braun P E, Goldman S A
Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York 10021, USA.
J Neurosci. 1999 Nov 15;19(22):9986-95. doi: 10.1523/JNEUROSCI.19-22-09986.1999.
Previous studies have suggested the persistence of oligodendrocyte progenitor cells in the adult mammalian subcortical white matter. To identify oligodendrocyte progenitors in the adult human subcortical white matter, we transfected dissociates of capsular white matter with plasmid DNA bearing the gene for green fluorescence protein (hGFP), placed under the control of the human early promoter (P2) for the oligodendrocytic protein cyclic nucleotide phosphodiesterase (P/hCNP2). Within 4 d after transfection with P/hCNP2:hGFP, a discrete population of small, bipolar cells were noted to express GFP. These cells were A2B5-positive (A2B5(+)), incorporated bromodeoxyuridine in vitro, and constituted <0.5% of all cells. Using fluorescence-activated cell sorting (FACS), the P/hCNP2-driven GFP(+) cells were then isolated and enriched to near-purity. In the weeks after FACS, most P/hCNP2:hGFP-sorted cells matured as morphologically and antigenically characteristic oligodendrocytes. Thus, the human subcortical white matter harbors mitotically competent progenitor cells, which give rise primarily to oligodendrocytes in vitro. By using fluorescent transgenes of GFP expressed under the control of an early oligodendrocytic promoter, these oligodendrocyte progenitor cells may be extracted and purified from adult human white matter in sufficient numbers for implantation and cell-based therapy.
先前的研究表明,成年哺乳动物的皮质下白质中存在少突胶质前体细胞。为了鉴定成年人类皮质下白质中的少突胶质前体细胞,我们用携带绿色荧光蛋白(hGFP)基因的质粒DNA转染被膜白质解离物,该基因置于少突胶质蛋白环核苷酸磷酸二酯酶(P/hCNP2)的人类早期启动子(P2)控制之下。在用P/hCNP2:hGFP转染后的4天内,注意到一群离散的小双极细胞表达GFP。这些细胞为A2B5阳性(A2B5(+)),在体外掺入溴脱氧尿苷,占所有细胞的比例不到0.5%。然后使用荧光激活细胞分选(FACS)分离并富集P/hCNP2驱动的GFP(+)细胞至接近纯品。在FACS后的几周内,大多数经P/hCNP2:hGFP分选的细胞成熟为形态和抗原特性典型的少突胶质细胞。因此,人类皮质下白质中存在有丝分裂活性的前体细胞,这些细胞在体外主要产生少突胶质细胞。通过使用在早期少突胶质启动子控制下表达的GFP荧光转基因,可以从成年人类白质中提取并纯化足够数量的这些少突胶质前体细胞用于植入和基于细胞的治疗。